AM
Akash Muduganti
About Akash Muduganti
Data last updated:
Akash Muduganti is a Director at Ruscorn Life Sciences Private Limited (since 2024) and Director at Bionor Pharmaceuticals Private Limited (since 2025). The companies operate in Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹8.6 Lakh; the largest is Ruscorn Life Sciences Private Limited at ₹5 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ruscorn Life Sciences Private Limited U47721GA2023PTC016048 | Director | 21 Dec 2024 | 2023 | ₹5 Lakh (FY 2024) | Active |
| Bionor Pharmaceuticals Private Limited U24230TG2019PTC136562 | Director | 28 Mar 2025 | 2019 | ₹3.6 Lakh (FY 2025) | Active |
Board colleagues of Akash Muduganti
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jithender Reddy Bollepally | 10256147 | Ruscorn Life Sciences Private Limited | Director |
| Karivedha Santosh Reddy | 07808693 | Bionor Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Akash Muduganti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akash Muduganti
Akash Muduganti currently holds 2 directorships: Ruscorn Life Sciences Private Limited (Director, since 21 Dec 2024, revenue ₹5 Lakh (FY 2024)); Bionor Pharmaceuticals Private Limited (Director, since 28 Mar 2025, revenue ₹3.6 Lakh (FY 2025)).
Akash Muduganti was first appointed on 21 Dec 2024 as Director at Ruscorn Life Sciences Private Limited. The most recent appointment on record is 28 Mar 2025 at Bionor Pharmaceuticals Private Limited.
The 2 current companies of Akash Muduganti that report revenue have a combined latest revenue of ₹8.6 Lakh: Ruscorn Life Sciences Private Limited ₹5 Lakh (FY 2024); Bionor Pharmaceuticals Private Limited ₹3.6 Lakh (FY 2025).
The current boards of Akash Muduganti's companies include Jithender Reddy Bollepally (Ruscorn Life Sciences Private Limited), Karivedha Santosh Reddy (Bionor Pharmaceuticals Private Limited).